Compounds selected from the group No. Structural formula and/or name "A1" 5-[5-(3-Methoxybenzyl)-[1,3,4]oxadiazol-2-ylamino]-1 H- indazole "A2" [5-(1 H -Indazol-5-ylamino)-[1,3,4]oxadiazol-2-yl]phenyl-methanol "A3" 5-(1 H -Indazol-5-ylamino)-[1,3,4]oxadiazole-2-carbohydrazide "A4" (1 H -Indazol-5-yl)-(5-phenoxymethyl-[1,3,4]oxadiazol-2-yl)-amine "A5" [5-(4-Chlorobenzenesulfonylmethyl)-[1,3,4]oxadiazol-2-yl]-(1 H -indazol-5-yl)amine "A6" 3-[5-(1 H -Indazol-5-ylamino)-[1,3,4]oxadiazol-2-ylmethyl]-phenol "A7" N(3-Fluorobenzyl)-N'-(1 H -indazol-5-yl)-[1,3,4]oxadiazole-2,5-diamine, hydrochloride "A8" N-(1 H -Indazol-5-yl)-N'-[ -1-(3-methoxyphenyl)ethyl]-[1,3,4]oxadiazole-2,5-diamine "A9" N-(4-Chloro-1 H -indazol-5-yl)-N'-[ -1-(3-methoxyphenyl)-ethyl]-[1,3,4]oxadiazole-2,5-diamine "A10" (4-Chloro-1 H -indazol-5-yl)-[5-(3-fluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A11" [5-(3-Amino-1 H -indazol-5-ylamino)-[1,3,4]oxadiazol-2-yl]-phenylmethanol "A12" N5-{5-[ -1-(3-Methoxyphenyl)ethylamino]-[1,3,4]oxadiazol-2-yl}-1 H -indazole-3,5-diamine "A13" N5-[5-(3-Fluorobenzylamino)-[1,3,4]oxadiazol-2-yl]-1 H- indazole-3,5-diamine "A14" [5-(3-Fluorobenzyl)-[1,3,4]oxadiazol-2-yl]-(3-furan-2-yl-1 H- indazol-5-yl)amine "A15" N-(3-Fluorobenzyl)-N'-(3-furan-2-yl-1 H -indazol-5-yl)-[1,3,4]oxadiazole-2,5-diamine "A16" N5-[5-(3-Methoxybenzyl)-[1,3,4]oxadiazol-2-yl]-1 H -indazole-3,5-diamine "A17" N5-[5-(3,4-Difluorobenzyl)-[1,3,4]oxadiazol-2-yl]-1 H- indazole-3,5-diamine "A18" N5-[5-(3,4-Dichlorobenzyl)-[1,3,4]oxadiazol-2-yl]-1 H- indazole-3,5-diamine "A19" N5-(5-Benzyl-[1,3,4]oxadiazol-2-yl)-1 H -indazole-3,5-diamine "A20" (5-Benzyl-[1,3,4]oxadiazol-2-yl)-(4-chloro-1 H -indazol-5-yl)-amine "A21" (4-Chloro-1 H -indazol-5-yl)-[5-(3,4-dichlorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A22" [5-(3-Chlorobenzyl)-[1,3,4]oxadiazol-2-yl]-(4-chloro-1 H- indazol-5-yl)amine "A23" (4-Chloro-1 H -indazol-5-yl)-[5-(3-methylbenzyl)-[1,3,4]oxadiazol-2-yl]amine "A24" (4-Chloro-1 H -indazol-5-yl)-[5-(3-methoxybenzyl)-[1,3,4]oxadiazol-2-yl]amine "A25" (4-Chloro-1 H -indazol-5-yl)-[5-(3,4-difluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A26" N-(4-Chloro-1 H -indazol-5-yl)-N'-[1-(3-fluorophenyl)ethyl]-[1,3,4]oxadiazole-2,5-diamine "A27" (5-Benzyl-[1,3,4]oxadiazol-2-yl)-(3-chloro-1 H -indazol-5-yl)-amine "A28" (3-Chloro-1 H -indazol-5-yl)-[5-(3-fluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A29" [5-(3-Chlorobenzyl)-[1,3,4]oxadiazol-2-yl]-(3-chloro-1 H- indazol-5-yl)amine "A30" (3-Chloro-1 H -indazol-5-yl)-[5-(3-methoxybenzyl)-[1,3,4]oxadiazol-2-yl]amine "A31" (3-Chloro-1 H -indazol-5-yl)-[5-(3,4-difluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A32" (3,4-Dichloro-1 H -indazol-5-yl)-[5-(3-methoxybenzyl)-[1,3,4]oxadiazol-2-yl]amine "A33" [5-(3-Methoxybenzyl)-[1,3,4]oxadiazol-2-yl]-[4-(3-methoxy-phenylsulfanyl)-1 H -indazol-5-yl]amine "A34" (4-Chloro-1 H -indazol-5-yl)-{5-[1-(3-methoxyphenyl)-1-methylethyl]-[1,3,4]oxadiazol-2-yl}amine "A35" (4-Chloro-1 H -indazol-5-yl)-[5-(3,4-difluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A36" (4-Chloro-1 H -indazol-5-yl)-{5-[1-(3-methoxyphenyl)ethyl]-[1,3,4]oxadiazol-2-yl}amine "A37" [5-(3-Fluorobenzyl)-[1,3,4]oxadiazol-2-yl]-[4-(3-methoxy-phenylsulfanyl)-1 H -indazol-5-yl]amine "A38" [5-(3-Fluorobenzyl)-[1,3,4]oxadiazol-2-yl]-(4-methyl-1 H- indazol-5-yl)amine "A39" (4-Bromo-1 H -indazol-5-yl)-[5-(3-methoxybenzyl)-[1,3,4]oxadiazol-2-yl]amine "A40" (4-Bromo-1 H -indazol-5-yl)-[5-(3-fluorobenzyl)-[1,3,4]oxadiazol-2-yl]amine "A41" 5-(4-Chlorobenzenesulfonylmethyl)-N3-(1 H -indazol-5-yl)-[1,2,4]triazole-3,4-diamine "A42" N3-(1 H -Indazol-5-yl)-5-(3-methoxybenzyl)-[1,2,4]triazole-3,4-diamine "A43" [5-(3-Methoxybenzyl)-[1,3,4]oxadiazol-2-yl]-(3-vinyl-1H-indazol-5-yl)amine "A44" [5-(3-Methoxybenzyl)-[1,3,4]oxadiazol-2-yl]-[3-( -styryl)-1H-indazol-5-yl]amine "A45" (3-Ethyl-1 H -indazol-5-yl)-[5-(3-methoxybenzyl)-[1,3,4]oxadiazol-2-yl]amine and pharmaceutically usable salts, solvates and stereoisomers thereof, including mixtures thereof in all ratios.